Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Ozempic

Semaglutide

Open in the dashboard

Part D claims

9,930,484

Prescriptions dispensed, refills included

Drug cost

$12,375,986,475

Paid at the pharmacy, in all

Prescribers

171,191

With 11 or more claims of it

In 2024, Medicare Part D recorded 9,930,484 claims for Ozempic (semaglutide) from 171,191 prescribers, at a total drug cost of $12.4 billion paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 59 states and territories

Part D claims for Ozempic by the state of the prescriber, 2024
State	Prescribers	Claims	Drug cost
CA	16,778	946,481	$1,043,125,364
TX	13,175	879,280	$1,137,651,146
FL	11,523	689,294	$871,305,065
NY	10,591	670,186	$860,555,675
PA	7,315	446,036	$548,980,361
NC	6,523	401,885	$506,362,279
OH	6,486	348,627	$437,163,405
GA	5,069	348,414	$442,216,724
IL	5,846	320,191	$417,423,595
MI	5,703	279,041	$370,603,186
TN	4,271	269,580	$336,575,252
IN	3,990	251,228	$330,204,420
NJ	3,749	225,688	$304,925,303
MO	3,519	222,325	$276,648,967
AL	2,726	220,436	$265,797,685

The other 44 states and territories

State	Prescribers	Claims	Drug cost
LA	2,919	206,150	$244,714,443
KY	3,136	206,048	$243,572,406
SC	3,036	192,251	$248,512,852
VA	3,707	191,225	$250,928,352
MA	3,647	185,469	$225,739,139
OK	2,442	170,871	$196,237,226
AZ	3,292	163,994	$215,832,296
WA	3,710	156,987	$199,428,748
WI	3,070	149,602	$186,376,223
MN	3,267	144,673	$183,035,134
CT	2,118	132,133	$176,693,362
MD	2,676	128,969	$181,978,401
AR	1,949	128,547	$143,670,257
MS	1,783	123,334	$153,191,369
IA	2,071	122,964	$142,452,041
OR	2,277	98,748	$118,889,098
KS	1,800	97,548	$112,867,826
WV	1,423	90,180	$117,457,222
CO	2,459	88,686	$109,798,237
NV	1,325	69,770	$94,199,666
NE	1,153	56,413	$62,410,644
ID	1,111	54,562	$63,121,688
NM	1,066	50,151	$59,668,554
UT	1,088	44,034	$53,127,799
ME	993	42,239	$52,142,045
PR	514	39,496	$41,050,337
NH	814	34,080	$43,782,174
RI	655	33,143	$35,957,688
DE	545	31,769	$48,480,435
HI	593	30,117	$45,447,260
MT	653	28,207	$32,589,184
ND	516	27,856	$32,572,748
SD	552	27,594	$31,198,470
VT	462	19,129	$23,238,921
AK	419	16,638	$21,550,469
DC	349	14,193	$18,517,559
WY	295	12,302	$14,061,136
AP	6	448	$626,661
VI	14	346	$412,984
GU	7	222	$222,477
MP	2	205	$192,829
XX	4	198	$214,365
ZZ	4	180	$163,260
AE	5	121	$124,061

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 96

Part D claims for Ozempic by prescriber specialty, 2024
Specialty	Prescribers	Claims	Drug cost
Family Practice	56,558	2,995,440	$3,619,342,579
Internal Medicine	39,730	2,500,441	$3,069,452,556
Nurse Practitioner	42,517	2,014,507	$2,500,539,249
Endocrinology	5,737	1,198,484	$1,726,520,892
Physician Assistant	14,819	690,993	$856,624,669
Cardiology	1,917	95,169	$111,974,914
General Practice	1,777	92,745	$107,255,746
Pharmacist	927	68,657	$66,105,446
Nephrology	950	45,238	$52,302,419
Emergency Medicine	506	26,712	$30,608,305
Hospitalist	655	24,162	$28,830,948
Student in an Organized Health Care Education/Training Program	1,319	24,112	$26,440,287
Geriatric Medicine	573	23,734	$29,106,734
Pediatric Medicine	348	16,859	$20,435,867
Interventional Cardiology	311	14,996	$17,531,410

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber	Specialty	State	Claims	Drug cost	Related payments
Eugenio Angueira-Serrano	Endocrinology	FL	5,444	$5,821,520	$4,324
Stella Ilyayeva	Internal Medicine	NY	3,061	$3,237,847	$214
Bashar Saad	Endocrinology	CA	2,138	$2,352,797	$120
Irina Urusova	Endocrinology	CA	1,999	$1,910,094	$94
Stephan Kowalyk	Endocrinology	PA	1,983	$2,294,737	$5,256

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Ozempic

$69,207,104 in general payments reported against it, with the companies and doctors behind them.

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for semaglutide

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.